Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|18|2847-2854

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.18, 2014-09, pp. : 2847-2854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Disease Improvement after Treatment with Everolimus plus Exemestane in a Patient with Hormone Receptor-Positive Metastatic Breast Cancer with Bone Metastases

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 101-105

Karger

Access to resources Recommend Favorite

Which Patients with Estrogen Receptor-Positive Early Breast Cancer Should Be Treated with Adjuvant Chemotherapy?

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Effects of Exemestane, Anastrozole and Tamoxifen on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Early Breast Cancer Patients: Results of N-SAS BC 04, the TEAM Japan Substudy

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 376-381

Karger

Access to resources Recommend Favorite

Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations

By  

Oncology, Vol. 93, Iss. 3, 2017-06 ,pp. : 143-156

Karger

Access to resources Recommend Favorite

Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer

By Leeper Alexander   Dixon J Michael  

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 357-360

Future Medicine

Access to resources Recommend Favorite